The mechanisms of secondary antibody diversification processes

Gregory Armstrong

Childhood Cancer Survivor Study

Hodgkin lymphoma Non-Hodgkin lymphoma

Pediatric oncology or childhood cancer

Carl F Ware

HVEM-BTLA Pathway in Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Smita Bhatia

Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction

Hodgkin lymphoma

Pediatric oncology or childhood cancer Radiation Oncology

James C Paulson

In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Peter C Adamson

COG NCTN Network Group Operations Center

Hodgkin lymphoma Non-Hodgkin lymphoma

Pediatric oncology or childhood cancer

Saro Armenian

Anthraycline-Related Cardiotoxicity in Long-Term Survivors of Lymphoma

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Monica M Bertagnolli

Alliance for Clinical Trials in Oncology Operations Center

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Non-Hodgkin lymphoma

Christian Steidl

Biology and clinical significance of the tumour microenvironment in lymphoid cancers

Non-Hodgkin lymphoma Hodgkin lymphoma

Pathology